JAGUAR HEALTH, INC. Earnings Per Share, Basic and Diluted
JAGUAR HEALTH, INC. (JAGX) reported Earnings Per Share, Basic and Diluted of -$0.10 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-13
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.10.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.10.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.21.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.44.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.00.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for fiscal 2019 was -$9.01.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for fiscal 2018 was -$153.27.
- JAGUAR HEALTH, INC. earnings per share, basic and diluted for fiscal 2017 was -$7.59.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.10 10-Q · filed 2021-08-13 | -$0.20 10-Q · filed 2021-08-13 | |||||
| 2021-03-31 | -$0.10 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | -$1.00 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | -$0.21 10-Q · filed 2020-11-16 | -$1.03 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | -$0.44 10-Q · filed 2021-08-13 | -$0.97 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | -$0.56 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | -$9.01 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | -$2.00 10-Q · filed 2020-11-16 | -$13.37 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | -$15.11 10-Q · filed 2020-08-13 | -$31.22 10-Q · filed 2020-08-13 | |||||
| 2019-03-31 | -$16.84 10-Q · filed 2020-05-15 | -$0.24 10-Q · filed 2019-05-21 | |||||
| 2018-12-31 | -$28.44 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$62.19 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$107.97 derived: net income ÷ weighted average shares · filed 2020-04-03 | -$153.27 10-K · filed 2020-04-03 | -$2.19 10-K · filed 2019-04-10 | ||
| 2018-09-30 | -$37.77 10-Q · filed 2019-11-14 | -$91.02 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$143.25 10-Q · filed 2019-11-14 | ||||
| 2018-06-30 | -$53.24 10-Q · filed 2019-08-14 | -$0.76 10-Q · filed 2018-08-13 | -$100.33 10-Q · filed 2019-08-14 | -$1.43 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | -$0.75 10-Q · filed 2019-05-21 | -$0.05 10-Q · filed 2018-05-15 | |||||
| 2017-12-31 | -$7.59 10-K · filed 2019-04-10 | -$0.51 10-K · filed 2018-04-09 | |||||
| 2017-06-30 | -$1.84 10-Q · filed 2018-08-13 | -$0.12 10-Q · filed 2017-08-09 | -$6.78 10-Q · filed 2018-08-13 | -$0.45 10-Q · filed 2017-08-09 | -$1.09 derived: net income ÷ weighted average shares · filed 2018-08-13 | -$1.39 derived: net income ÷ weighted average shares · filed 2018-08-13 | |
| 2017-03-31 | -$0.33 10-Q · filed 2018-05-15 | -$0.62 derived: net income ÷ weighted average shares · filed 2018-05-15 | -$0.92 derived: net income ÷ weighted average shares · filed 2018-05-15 | -$1.27 derived: net income ÷ weighted average shares · filed 2018-05-15 | |||
| 2016-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2018-04-09 | -$0.59 derived: net income ÷ weighted average shares · filed 2018-04-09 | -$0.94 derived: net income ÷ weighted average shares · filed 2018-04-09 | -$1.35 10-K · filed 2018-04-09 | |||
| 2016-09-30 | -$0.30 10-Q · filed 2016-11-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2017-11-20 | -$1.07 10-Q · filed 2016-11-14 | -$1.56 derived: net income ÷ weighted average shares · filed 2017-11-20 | |||
| 2016-06-30 | -$0.35 10-Q · filed 2017-08-09 | -$0.78 10-Q · filed 2017-08-09 | -$1.27 derived: net income ÷ weighted average shares · filed 2017-08-09 | -$1.64 derived: net income ÷ weighted average shares · filed 2017-08-09 | |||
| 2016-03-31 | -$0.43 10-Q/A · filed 2017-06-23 | -$0.93 derived: net income ÷ weighted average shares · filed 2017-06-23 | -$1.30 derived: net income ÷ weighted average shares · filed 2017-06-23 | -$2.13 derived: net income ÷ weighted average shares · filed 2017-06-23 | |||
| 2015-12-31 | -$0.51 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$0.87 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$1.73 derived: net income ÷ weighted average shares · filed 2017-02-15 | -$2.70 10-K · filed 2017-02-15 | |||
| 2015-09-30 | -$0.36 10-Q · filed 2016-11-14 | -$1.24 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$2.28 10-Q · filed 2016-11-14 | -$3.04 derived: net income ÷ weighted average shares · filed 2016-11-14 | |||
| 2015-06-30 | -$1.00 10-Q · filed 2016-08-15 | -$2.30 10-Q · filed 2016-08-15 | -$3.14 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$4.16 derived: net income ÷ weighted average shares · filed 2016-08-15 | |||
| 2015-03-31 | -$1.43 10-Q · filed 2016-05-10 | -$2.18 derived: net income ÷ weighted average shares · filed 2016-05-10 | -$3.20 derived: net income ÷ weighted average shares · filed 2016-05-10 | -$3.94 derived: net income ÷ weighted average shares · filed 2016-05-10 | |||
| 2014-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2016-03-29 | -$1.76 derived: net income ÷ weighted average shares · filed 2016-03-29 | -$2.51 derived: net income ÷ weighted average shares · filed 2016-03-29 | -$3.24 10-K · filed 2016-03-29 | |||
| 2014-09-30 | -$1.01 10-Q · filed 2015-11-13 | -$1.76 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$2.49 10-Q · filed 2015-11-13 | ||||
| 2014-06-30 | -$0.75 10-Q · filed 2015-08-13 | -$1.48 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | -$0.73 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |